Pivatto Júnior, Fernando, et al. “Major Bleeding Risk Assessment in Atrial Fibrillation Patients Taking Vitamin K Antagonists”. Clinical and Biomedical Research, vol. 35, nº 2, julho de 2015, doi:10.22491/2357-9730.54273.